Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $103,102 | 56 | 69.9% |
| Travel and Lodging | $31,523 | 136 | 21.4% |
| Food and Beverage | $7,889 | 138 | 5.3% |
| Consulting Fee | $5,000 | 2 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Vanda Pharmaceuticals Inc. | $68,622 | 124 | $0 (2024) |
| Alkermes, Inc. | $36,499 | 87 | $0 (2024) |
| ABBVIE INC. | $29,545 | 89 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $7,299 | 12 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $3,552 | 5 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $848.35 | 7 | $0 (2022) |
| Allergan, Inc. | $825.00 | 1 | $0 (2021) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $141.70 | 2 | $0 (2024) |
| Biogen, Inc. | $68.54 | 1 | $0 (2024) |
| ITI, Inc. | $60.48 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $69,047 | 133 | Vanda Pharmaceuticals Inc. ($68,029) |
| 2023 | $22,929 | 70 | ABBVIE INC. ($11,875) |
| 2022 | $38,843 | 81 | Alkermes, Inc. ($22,902) |
| 2021 | $16,696 | 48 | AbbVie Inc. ($9,262) |
All Payment Transactions
332 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/11/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $119.59 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/04/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/04/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Travel and Lodging | Cash or cash equivalent | $399.46 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/04/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Travel and Lodging | Cash or cash equivalent | $142.07 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/04/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Travel and Lodging | Cash or cash equivalent | $126.86 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/04/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/04/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $12.32 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/03/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Travel and Lodging | Cash or cash equivalent | $441.95 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/20/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/20/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Travel and Lodging | Cash or cash equivalent | $348.22 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/20/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Travel and Lodging | Cash or cash equivalent | $291.55 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/20/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Travel and Lodging | Cash or cash equivalent | $173.98 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/20/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $113.00 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/20/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $40.20 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/08/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $104.17 | General |
| Category: CNS | ||||||
| 11/07/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $92.59 | General |
| Category: CNS | ||||||
| 11/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $126.69 | General |
| Category: Neuropsychiatry | ||||||
| 10/30/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/30/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Travel and Lodging | Cash or cash equivalent | $641.96 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/30/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Travel and Lodging | Cash or cash equivalent | $126.15 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/30/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $124.73 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/30/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Travel and Lodging | Cash or cash equivalent | $100.10 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/30/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $63.66 | General |
| Category: SCHIZOPHRENIA | ||||||
About Deborah York, NP
Deborah York, NP is a Psychiatric/Mental Health healthcare provider based in Denver, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/16/2017. The National Provider Identifier (NPI) number assigned to this provider is 1952823403.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Deborah York, NP has received a total of $147,514 in payments from pharmaceutical and medical device companies, with $69,047 received in 2024. These payments were reported across 332 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($103,102).
Practice Information
- Specialty Psychiatric/Mental Health
- Location Denver, CO
- Active Since 07/16/2017
- Last Updated 03/11/2025
- Taxonomy Code 363LP0808X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1952823403
Products in Payments
- FANAPT (Drug) $68,622
- LYBALVI (Drug) $35,870
- VRAYLAR (Drug) $30,330
- INGREZZA (Drug) $3,428
- ARISTADA (Drug) $509.41
- CAPLYTA (Drug) $202.18
- ONGENTYS (Drug) $123.22
- Vivitrol (Drug) $119.47
- ZURZUVAE (Drug) $68.54
- LATUDA (Drug) $55.85
- Auvelity (Drug) $53.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Denver
Audrey Strock, Dnp, Agpcnp, Pmhnp, DNP, AGPCNP, PMHNP
Psychiatric/Mental Health — Payments: $321,139
Mary Evans
Psychiatric/Mental Health — Payments: $6,637
Kristina Mordecai
Psychiatric/Mental Health — Payments: $5,719
Ivy Hoo
Psychiatric/Mental Health — Payments: $5,683
Brandon Burelle, Pmhmp-Bc, PMHMP-BC
Psychiatric/Mental Health — Payments: $5,039
Margeaux King, Np, NP
Psychiatric/Mental Health — Payments: $3,776